1. Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Aug 6;52(8):822-826. doi: 
10.3760/cma.j.issn.0253-9624.2018.08.009.

[A promoter polymorphism of CD55 effect on the risk of esophageal cancer].

[Article in Chinese; Abstract available in Chinese from the publisher]

Wu HJ(1), Gao H, Xie YN, Zhang YY, Yang ZB, Zhang XM.

Author information:
(1)College of Life Science, North China University of Science and Technology, 
Tangshan 063000, China.

Objective: This study aimed to investigate the relationship between the genetic 
variation of CD55 promoter and the risk of esophageal cancer. Methods: A total 
of 700 esophageal cancer patients recruited between April 2008 and December 2012 
at Tangshan Grongren Hospital and Tangshan Renmin Hospital, and 700 frequency 
matched controls were randomly selected from a pool of cancer free subjects 
recruited from a nutritional survey. Genotypes of CD55 rs2564978 polymorphism 
among all subjects were conducted by polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP). The OR and 95%CI were calculated by 
non-conditional Logistic regression to evaluate the association of CD55 
rs2564978T/C polymorphism with the risk of esophageal cancer. Results: The 
average age of cases and control was (60.04±9.19) and (59.21±9.98) years old. 
Compared with CD55 rs2564978 TT carriers, the individuals with CC genotype had a 
significantly higher risk of esophageal cancer (OR=1.94, 95%CI:1.42-2.66) . When 
stratified by sex, this genetic variation affected the risk of esophageal cancer 
among both males (OR=1.92, 95%CI:1.37-2.70) and females (OR=2.34, 
95%CI:1.04-5.27). When stratified by age, the CD55 rs2564978 CC was associated 
with the susceptibility of developing esophageal cancer among younger 
individuals (OR=1.79, 95%CI:1.19-2.68) and older people (OR=2.32, 
95%CI:1.41-3.83).When stratified by drinking status, CC genotype carriers 
increase the risk of esophageal cancer when drinking (OR=1.93, 95%CI:1.03-3.63) 
or not drinking (OR=1.95, 95%CI:1.36-2.80). When stratified by smoking status, 
CC genotype was associated with the risk of esophageal cancer among non-smokers 
(OR=1.79, 95%CI: 1.13-2.83), light smokers (less than 30 packs/year, OR=1.86, 
95%CI:1.31-2.64) and heavy smokers (more than 30 packs/year, OR=2.67, 
95%CI:1.28-5.57). Gene-environmental interaction analysis showed that CD55 
rs2564978T/C polymorphism interacted with smoking status to increase the risk of 
esophageal cancer. Conclusion: CD55 rs2564978 polymorphism effects on the risk 
of esophageal cancer.

Publisher: 目的： 探讨补体因子CD55启动子遗传变异与食管癌发病风险的相关性。 方法： 
以2008年4月至2012年12月在华北理工大学附属唐山市工人医院和唐山市人民医院就诊的700例食管癌患者作为病例组，健康对照来自同期健康体检个体，以无肿瘤病史和体征者作为对照组，共700名。采用PCR-限制性片段长度多态性（PCR-RFLP）方法，对700例食管癌患者和700名正常对照者进行CD55 
rs2564978基因分型。采用非条件logistic回归模型比较CD55 rs2564978变异与食管癌发病风险的关系。 结果： 
病例组和对照组的年龄分别为（60.04±9.19）、（59.21±9.98）岁。与CD55 rs2564978 
TT基因型携带者相比，CC基因型携带者患食管癌OR（95%CI）为1.94（1.42~2.66）；不同性别分析显示，携带CC基因型的男、女性与食管癌发病的OR（95%CI）分别为1.92（1.37~2.70）、2.34（1.04~5.27）；不同年龄组中，≤60、>60岁CC基因型携带者与食管癌发病的OR（95%CI）分别为1.79（1.19~2.68）、2.32（1.41~3.83）。同时，在调整了其他变量后，饮酒、不饮酒的CC基因型携带者与食管癌发病的OR（95%CI）分别为1.93（1.03~3.63）、1.95（1.36~2.80）。吸烟状况分层分析显示，与CD55 
rs2564978 
TT基因型相比，CC基因型中的非吸烟人群、累计吸烟量≤30包/年、累计吸烟量>30包/年的人群食管癌发病的OR（95%CI）分别为1.79（1.13~2.83）、1.86（1.31~2.64）和2.67（1.28~5.57）。吸烟和CD55 
rs2564978通过交互作用影响食管癌发病风险（P=0.001）。 结论： CD55启动子区rs2564978遗传变异可能与食管癌发病相关。.

DOI: 10.3760/cma.j.issn.0253-9624.2018.08.009
PMID: 30107716 [Indexed for MEDLINE]